Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tiotropium plus salmeterol/fluticasone with or without inhaled corticosteroid withdrawal in severe COPD
CTR20132617Phase 4Completed
- Sponsor
- Boehringer Ingelheim
- Start
- Nov 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of tiotropium in chronic obstructive pulmonary disease (COPD), sponsored by Boehringer Ingelheim. Started Nov 2014; status: completed.
02
Drugs
tiotropium
03
Conditions
chronic obstructive pulmonary disease (COPD)
Beyond the preview
Go deeper on CTR20132617.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20132617.